Impact of High-Dose Radiation on the Host Immune System in Cancer Treatments

Overview of Non-Small Cell Lung Cancer

More than 80% of lung cancer cases are classified as non-small cell lung cancer (NSCLC), primarily affecting current or former smokers. Treatment strategies for NSCLC are largely determined by the cancer’s stage. For stage 3 NSCLC, radiation therapy is commonly combined with surgery and chemotherapy, utilizing high-energy X-rays to target and destroy rapidly dividing cancer cells. Despite its widespread use, the effects of radiation dosage on the host immune system during cancer treatment remain unclear.

Research Study on Radiation Dose and Survival Rates

A recent study published in the *International Journal of Radiation Oncology, Biology, Physics* details a phase 3 clinical trial led by researchers at the University of Colorado, USA. The study aimed to explore the relationship between radiation dose and survival rates in patients with stage 3 non-small cell lung cancer.

The researchers analyzed data from 117 patients treated at UC Health University of Colorado Hospital from 2004 to 2017. Their objective was to evaluate how the estimated radiation dose to immune cells influenced cancer-specific outcomes, including lung and heart functionality.

Findings and Implications

After a median follow-up period of 16 months, the study revealed significant findings. Patients who received high-dose radiation had a median survival of 14.3 months, in contrast to 28.2 months for those who underwent low-dose treatment. The research team concluded that the estimated radiation dose to immune cells serves as a crucial predictor of tumor control and overall survival.

These findings indicate that higher radiation doses may correlate with increased tumor progression and mortality in patients treated for stage 3 non-small cell lung cancer. The researchers suggest that personalizing radiotherapy could be a vital strategy for enhancing treatment outcomes in this patient demographic.

Research Reference

Written by Man-tik Choy, Ph.D.
Reference: Ladbury C.J. et al. Impact of Radiation Dose to the Host Immune System on Tumor Control and Survival for Stage III Non-Small Cell Lung Cancer Treated with Definitive Radiotherapy. *International Journal of Radiation Oncology, Biology, Physics*, Accepted Manuscript. DOI: 10.1016/j.ijrobp.2019.05.064.